The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 03, 2025

Filed:

Oct. 26, 2016
Applicant:

Translate Bio Ma, Inc., Lexington, MA (US);

Inventors:

Fatih Ozsolak, Boston, MA (US);

Balkrishen Bhat, Carlsbad, CA (US);

Assignee:

Translate Bio MA, Inc., Lexington, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/51 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2025.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61L 24/04 (2006.01); B82Y 5/00 (2011.01); C07K 14/705 (2006.01); C07K 14/775 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5153 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/0073 (2013.01); A61K 9/127 (2013.01); A61K 9/1647 (2013.01); A61K 9/19 (2013.01); A61K 9/5123 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61L 24/046 (2013.01); B82Y 5/00 (2013.01); C07K 14/705 (2013.01); C07K 14/775 (2013.01); C12N 15/111 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/346 (2013.01); C12N 2320/00 (2013.01);
Abstract

Aspects of the disclosure relate to particle formulations, e.g., nanoparticle formulations, methods of making particle formulations, and methods for delivery of oligonucleotides and/or synthetic RNA, e.g., for increasing gene expression in a targeted manner. In some embodiments, compositions and methods are provided that are useful for posttranscriptionally altering protein and/or RNA levels in a targeted manner. Aspects of the disclosure described herein provide compositions and methods that are useful for protecting RNAs from degradation (e.g., exonuclease mediated degradation).


Find Patent Forward Citations

Loading…